334
Participants
Start Date
June 16, 2016
Primary Completion Date
October 31, 2026
Study Completion Date
October 31, 2026
TAK-788
TAK-788 capsules.
National Taiwan University Hospital, Taipei
Taichung Veterans General Hospital, Taichung
National Taiwan University Hospital - YunLin Branch, Douliu
Memorial Sloan Kettering Cancer Center, New York
Seoul National University Bundang Hospital, Seongnam-si
HELIOS Klinikum Emil von Behring, Berlin
Complejo Hospitalario Universitario A Coruna, A Coruña
Istituto Di Ricovero E Cura A Carattere Scientifico - Istituto Europeo Di Oncologia, Milan
Virginia Cancer Specialists - Fairfax Office, Fairfax
University of Virginia Cancer Center, Charlottesville
Levine Cancer Institute, Charlotte
Carolinas Healthcare System, Charlotte
Winship Cancer Institute, Atlanta
AdventHealth Orlando, Orlando
Brookwood Medical Center, Birmingham
SCRI - Tennessee Oncology - Nashville - Centennial, Nashville
University of Virginia Cancer Center, Nashville
Thompson Oncology Group - Knoxville - Downtown, Knoxville
Azienda Ospedaliero Universitaria di Parma, Parma
Investigative Clinical Research - Indiana, Indianapolis
University of Michigan Comprehensive Cancer Center, Ann Arbor
The University of Chicago Medicine, Chicago
Siteman Cancer Center - Washington University Medical Campus, St Louis
Thoraxklinik Heidelberg, Heidelberg
National Cheng Kung University Hospital, Tainan City
Hightower Clinical, Oklahoma City
The University of Texas MD Anderson Cancer Center, Houston
Lumi Research, Houston
University of Colorado Cancer Center, Aurora
Banner MD Anderson Cancer Center, Gilbert
The Oncology Institute of Hope and Innovation - West Tucson, Tucson
The Oncology Institute of Hope and Innovation, Whittier
Cancer and Blood Specialty Clinic, Los Alamitos
Pacific Shores Medical Group-Long Beach Elm, Long Beach
City of Hope Comprehensive Cancer Center - Duarte, Duarte
University of California San Diego Moores Cancer Center, La Jolla
Compassionate Cancer Care - Fountain Valley, Fountain Valley
University of California Irvine Health Chao Family Comprehensive Cancer Center, Orange
SLO Oncology and Hematology Health Center, San Luis Obispo
Stanford Cancer Center - Palo Alto, Palo Alto
Oregon Health and Science University, Portland
Swedish Cancer Institute, Seattle
Peking University Cancer Hospital/Beijing Cancer Hospital, Beijing
Beijing Chest Hospital, Beijing
Shanghai Pulmonary Hospital, Shanghai
The First Affiliated Hospital, Zhejiang University, Hangzhou
Hubei Cancer Hospital, Wuhan
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dana Farber Cancer Institute, Boston
Atlantic Health - Morristown Medical Center, Morristown
National Cancer Center Hospital East, Kashiwa
Kurume University Hospital, Kurume-shi
Sendai Kousei Hospital, Sendai
Kindai University Hospital, Ōsaka-sayama
In Situ Global Clinical Trials Network, Manatí
Seoul National University Hospital, Seoul
Severance Hospital, Seoul
Asan Medical Center, Seoul
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Clinic de Barcelona, Barcelona
The Royal Marsden NHS Foundation Trust, London
Lead Sponsor
Takeda
INDUSTRY